Jeremy D Keenan

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
  2. ncbi Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?
    Jeremy D Keenan
    Francis I Proctor Foundation, San Francisco, CA 94143 0412, USA
    Trop Med Int Health 17:392-6. 2012
  3. ncbi Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
  4. ncbi Childhood mortality in a cohort treated with mass azithromycin for trachoma
    Jeremy D Keenan
    F I Proctor Foundation, San Francisco, CA, USA
    Clin Infect Dis 52:883-8. 2011
  5. ncbi Granulomatous inflammation in juvenile idiopathic arthritis-associated uveitis
    Jeremy D Keenan
    University of Illinois Eye and Ear Infirmary, Chicago, Illnois, USA
    J AAPOS 12:546-50. 2008
  6. ncbi Peripheral ulcerative keratitis associated with vasculitis manifesting asymmetrically as fuchs superficial marginal keratitis and terrien marginal degeneration
    Jeremy D Keenan
    F I Proctor Foundation, University of California, San Francisco, CA, USA
    Cornea 30:825-7. 2011
  7. ncbi Perifosine-related rapidly progressive corneal ring infiltrate
    Jeremy D Keenan
    F I Proctor Foundation and the Department of Ophthalmology, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 29:583-5. 2010
  8. ncbi Retinopathy in nondiabetic persons with the metabolic syndrome: findings from the Third National Health and Nutrition Examination Survey
    Jeremy D Keenan
    University of Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, USA
    Am J Ophthalmol 147:934-44, 944.e1-2. 2009
  9. ncbi Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
  10. ncbi How reliable are tests for trachoma?--a latent class approach
    Craig W See
    F I Proctor Foundation, University of California San Francisco, San Francisco, California 94143 0412, USA
    Invest Ophthalmol Vis Sci 52:6133-7. 2011

Collaborators

Detail Information

Publications20

  1. ncbi Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
    Jeremy D Keenan
    F I Proctor Foundation, 513 Parnassus Avenue, Med Sci S309, Box 0412, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:235-40. 2012
    ....
  2. ncbi Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?
    Jeremy D Keenan
    Francis I Proctor Foundation, San Francisco, CA 94143 0412, USA
    Trop Med Int Health 17:392-6. 2012
    ..We sought to determine whether individuals who are difficult to locate were more likely to be infected with ocular chlamydia than those who were easier to locate...
  3. ncbi Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma
    Jeremy D Keenan
    FI Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, CA 94143 0412, USA
    Clin Infect Dis 54:253-6. 2012
    ..An RNA-based test detected ocular chlamydial infection in more children than did a DNA-based test (6.9% vs 4.2%), and in a larger number of communities (8 vs 7)...
  4. ncbi Childhood mortality in a cohort treated with mass azithromycin for trachoma
    Jeremy D Keenan
    F I Proctor Foundation, San Francisco, CA, USA
    Clin Infect Dis 52:883-8. 2011
    ..Here, we monitor a large cohort in which almost 90% of individuals received azithromycin. We assess whether receiving treatment is associated with reduced all-cause and infectious childhood mortality...
  5. ncbi Granulomatous inflammation in juvenile idiopathic arthritis-associated uveitis
    Jeremy D Keenan
    University of Illinois Eye and Ear Infirmary, Chicago, Illnois, USA
    J AAPOS 12:546-50. 2008
    ..The uveitis that is associated with juvenile idiopathic arthritis (JIA) has typically been described as nongranulomatous. This study reports the prevalence of granulomatous disease in a population with JIA-associated uveitis...
  6. ncbi Peripheral ulcerative keratitis associated with vasculitis manifesting asymmetrically as fuchs superficial marginal keratitis and terrien marginal degeneration
    Jeremy D Keenan
    F I Proctor Foundation, University of California, San Francisco, CA, USA
    Cornea 30:825-7. 2011
    ..To report a case of bilateral peripheral corneal thinning with an appearance of Fuchs superficial marginal keratitis in the right eye and Terrien marginal degeneration in the left eye...
  7. ncbi Perifosine-related rapidly progressive corneal ring infiltrate
    Jeremy D Keenan
    F I Proctor Foundation and the Department of Ophthalmology, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 29:583-5. 2010
    ..To report a case of unilateral rapidly progressing corneal ring infiltration in a patient being treated with the investigational drug perifosine for Waldenström's macroglobulinemia...
  8. ncbi Retinopathy in nondiabetic persons with the metabolic syndrome: findings from the Third National Health and Nutrition Examination Survey
    Jeremy D Keenan
    University of Illinois Eye and Ear Infirmary, Department of Ophthalmology and Visual Sciences, Chicago, Illinois, USA
    Am J Ophthalmol 147:934-44, 944.e1-2. 2009
    ..To study whether the metabolic syndrome is associated with retinopathy independent of the presence of diabetes...
  9. ncbi Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma
    Jeremy D Keenan
    Department of Ophthalmology, University of California, San Francisco, CA, USA
    Am J Trop Med Hyg 82:482-7. 2010
    ....
  10. ncbi How reliable are tests for trachoma?--a latent class approach
    Craig W See
    F I Proctor Foundation, University of California San Francisco, San Francisco, California 94143 0412, USA
    Invest Ophthalmol Vis Sci 52:6133-7. 2011
    ..Latent class analysis (LCA) was performed to estimate the sensitivity and specificity of laboratory and clinical tests for trachoma in the absence of a gold standard...
  11. ncbi Association of conjunctival bacterial infection and female sex in cicatricial trachoma
    Vicky Cevallos
    Francis I Proctor Foundation, San Francisco, California 94143 0412, USA
    Invest Ophthalmol Vis Sci 53:5208-12. 2012
    ..To further characterize the microbiological profile of bacterial conjunctival infections in cicatricial trachoma, a conjunctival swabbing of adults in rural Ethiopia was performed...
  12. ncbi Travel and implications for the elimination of trachoma in ethiopia
    Neelima A Shah
    Department of Public Health Sciences, University of California, Davis, California, USA
    Ophthalmic Epidemiol 17:113-7. 2010
    ..Seven hundred and seventeen households with at least one child aged 1-5 years in 48 villages were surveyed to collect the details of travel in 1 month prior to the survey...
  13. ncbi When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries
    Kathryn J Ray
    F I Proctor Foundation, University of California, San Francisco, California, United States of America
    PLoS Negl Trop Dis 3:e458. 2009
    ..While this can be tested empirically, results will not be available for years. Here we use a mathematical model to predict results with different graduation strategies in three African countries...
  14. ncbi The clinical differentiation of bacterial and fungal keratitis: a photographic survey
    Cyril Dalmon
    F I Proctor Foundation and Department of Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Invest Ophthalmol Vis Sci 53:1787-91. 2012
    ..The purpose of this study was to determine whether clinical signs of infectious keratitis can be used to identify the causative organism...
  15. ncbi Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial
    Jenafir I House
    FI Proctor Foundation, University of California, San Francisco, USA
    Lancet 373:1111-8. 2009
    ..We assessed indirect protection against trachoma with mass azithromycin distributions...
  16. ncbi Comparison of autophotomontage software programs in eyes with CMV retinitis
    Jenny Chen
    F I Proctor Foundation, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 52:9339-44. 2011
    ..This study compares the quality of the mosaic products of three autophotomontage software programs, using digital fundus photographs of eyes with cytomegalovirus (CMV) retinitis...
  17. ncbi Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 30:1363-8. 2011
    ..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
  18. ncbi Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures
    Robert E Fintelmann
    Francis I Proctor Foundation for Research in Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0412, USA
    Arch Ophthalmol 129:399-402. 2011
    ..To determine whether recent use of topical fluoroquinolones is a risk factor for in vitro fluoroquinolone resistance in Staphylococcus aureus ocular isolates...
  19. ncbi Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial
    Alison H Skalet
    Francis I Proctor Foundation for Research in Opthalmology, University of California, San Francisco, San Francisco, California, United States of America
    PLoS Med 7:e1000377. 2010
    ..In this study, we used a randomized clinical trial design to assess whether macrolide resistance was higher in communities treated with mass azithromycin for trachoma, compared to untreated control communities...
  20. ncbi Predictors of matching in an ophthalmology residency program
    Allison R Loh
    Department of Ophthalmology, University of California San Francisco, San Francisco, California
    Ophthalmology 120:865-70. 2013
    ..To examine the characteristics of US medical students applying for ophthalmology residency and to determine the predictors of matching...